Patient Leaflet Updated 10-Oct-2025 | Aspargo Labs Italia
Hezkue PIL
Hezkue® 12.5mg/actuation, oromucosal spray, suspension
Sildenafil
1. What Hezkue® is and what is it used for
2. What you need to know before you take Hezkue®
3. How to take Hezkue®
4. Possible side effects
5. How to store Hezkue®
6. Contents of the pack and other information
Hezkue® contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 (PDE5) inhibitors. It works by helping to relax the blood vessels in your penis, allowing blood to flow into your penis when you get sexually excited. Hezkue® will only help you to get an erection if you are sexually stimulated.
Hezkue® is a treatment for adult men with erectile dysfunction, sometimes known as impotence. This is when a man cannot get, or keep a hard, erect penis suitable for sexual activity.
Check with your doctor before taking Hezkue®:
You should not use Hezkue® with any other oral or local treatments for erectile dysfunction.
You should not use Hezkue® with treatments for pulmonary arterial hypertension (PAH) containing sildenafil or any other PDE5 inhibitors.
You should not take Hezkue® if you do not have erectile dysfunction.
You should not take Hezkue® if you are a woman.
Special considerations for patients with kidney or liver problems
You should tell your doctor if you have kidney or liver problems. Your doctor may decide on a lower dose for you.
Do not give this medicine to children and adolescents under 18 years of age.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Hezkue® may interfere with some medicines, especially those used to treat chest pain. In the event of a medical emergency, you should tell your doctor, pharmacist or nurse that you have taken Hezkue® and when you did. Do not take Hezkue® with other medicines unless your doctor tells you that you can.
You should not take Hezkue® if you are taking medicines called nitrates, as the combination of these medicines may lead to a dangerous fall in your blood pressure. Always tell your doctor, pharmacist or nurse if you are taking any of these medicines that are often used for the relief of angina pectoris (or “chest pain”).
You should not take Hezkue® if you are using any of the medicines known as nitric oxide donors such as amyl nitrite (“poppers”) as the combination may also lead to a dangerous fall in your blood pressure.
Tell your doctor or pharmacist if you are already taking Riociguat.
If you are taking medicines known as protease inhibitors, such as for the treatment of HIV, your doctor may start you on the lowest dose (1 ml is equivalent to 25 mg of sildenafil) of Hezkue®.
Some patients who take alpha-blocker therapy for the treatment of high blood pressure or prostate enlargement may experience dizziness or light-headedness, which may be caused by low blood pressure upon sitting or standing up quickly. Certain patients have experienced these symptoms when taking Hezkue® with alpha-blockers. This is most likely to happen within 4 hours after taking Hezkue®. To reduce the chance that these symptoms might happen, you should be on a regular daily dose of your alpha-blocker before you start Hezkue®. Your doctor may start you on a lower dose (1 ml is equivalent to 25 mg of sildenafil) of Hezkue®.
Tell your doctor or pharmacist if you are taking medicines containing sacubitril/valsartan, used to treat heart failure.
Hezkue® can be taken with or without food. However, you may find that Hezkue® takes longer to start working if you take it with a heavy meal.
Drinking alcohol can temporarily impair your ability to get an erection. To get the maximum benefit from your medicine, you are advised not to drink excessive amounts of alcohol before taking this medicine.
Hezkue® is not indicated for use in women.
Hezkue® can cause dizziness and can affect vision. You should be aware of how you react to medicine before you drive or use machinery.
This medicinal product contains less than 1mmol (23 mg) of sodium benzoate per ml of suspension.
Patients on low sodium diets can be informed that this medicinal product is essentially ‘sodium-free’.
Always take Hezkue® exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is 2 ml equivalent to 50 mg (4 pumps). Each press of the dosing pump releases 0.5 ml of suspension containing 12.5 mg of sildenafil.
If this medicine does not help you to get an erection, or if your erection does not last long enough for you to complete sexual intercourse you should tell your doctor.
Your doctor may then recommend a decrease or increase of the dose to 1 ml of the suspension equivalent to 25 mg (2 pumps), or 4 ml of suspension equivalent to 100 mg (8 pumps).
You should take Hezkue® about an hour before you plan to have sex. Hezkue® should not be taken more than once a day.
Do not take Hezkue® together with other medications that contain sildenafil.
This medication is to be administered orally. Do not administer this medicine via the nose and do not apply this medicine on the skin. Your doctor will prescribe you the correct number of doses you need. For a correct administration, please follow the Instructions for Use. Always use the pump supplied with the pack.
Shake the bottle vigorously for approximately 20 seconds to ensure that the medicine is mixed in the bottle before each use (Fig 1).
Remove the child-resistant screw cap by pushing it down firmly and turning it anticlockwise. (Fig 2)
Place the dosage pump on top of the bottle, sliding the plastic tube carefully into the liquid in the bottle. Hold the dosing pump onto the neck of the bottle and screw clockwise until it is firmly attached to the bottle. (Fig 3)
Turn the nozzle on the dosing pump to the open position. (Fig 4)
Before every use (including first-time use): Activate the pump three times to prepare (prime) the dosage pump, discard any product released during this activation into an absorbent material.
The pump is now ready to be used and each metered spray delivers an average of 12.5 mg of sildenafil.
A failure in this priming process may lead to a lower dose when used.
Tilt your head back a little. Open your mouth and put the bottle next to your chin (see picture). Press the dosage pump as many times as required, according to the dose prescribed by your doctor. Apply the suspension onto the tongue and swallow the suspension immediately with saliva. Avoid direct contact between the end of the dosage pump and the inside of the mouth and tongue. (Fig 5)
Turn the nozzle on the dosage pump to the closed position. (Fig 6)
Remove the pump from the bottle unscrewing anticlockwise. Tap the plastic tube against the internal wall of the bottle to remove any excess liquid. (Fig 7)
Put the child resistant screw cap back on the bottle and turn clockwise to close it immediately after each use. (Fig 8)
Wash the dosage pump thoroughly with water. Ensure no product or water remains in the pump by activating the pump several times into an absorbent material. Allow the pump to dry thoroughly before the next use. (Fig 9 & 10)
NOTE FOR PATIENTS – Hezkue® requires priming before each dose and washing of the dosing pump after each use. Therefore, a small amount of product is discarded with each use. The approximate volume of Hezkue® that is used is 20 ml in each 30 ml bottle.
Once the volume of the product in the bottle goes below the red line (marked on the bottom of the bottle), stop using Hezkue® and discard.
You may experience an increase in side effects and their severity.
You should not take more doses than your doctor tells you to.
Contact your doctor if you take more doses than you should.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Infrequent (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
From post-marketing experience cases of unstable angina (a heart condition) and sudden death have been reported rarely. Of note, most, but not all, of the men who experienced these side effects had heart problems before taking this medicine. It is not possible to determine whether these events were directly related to sildenafil.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card scheme on the MHRA website (www.yellowcard.mhra.gov.uk) or with the MHRA Yellow Card app in the Google Play or Apple App Store.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use Hezkue® after the expiry date which is stated on the carton and bottle as “EXP”. The expiry date refers to the last day of that month. The expiry date after first opening of the bottle is 10 months. Fill in the date of first opening in the space on the box to know when this expiry date has been reached.
This medicinal product does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer required. These measures will help to protect the environment.
The active substance is sildenafil.
Each ml (corresponds to TWO pumps) of suspension contains 25 mg of sildenafil.
The other ingredients are:
sodium benzoate, anhydrous citric acid, sucralose, acesulfame potassium, hypromellose, xanthan gum, peppermint flavour, masking flavour, purified water
Hezkue® is white to off-white oromucosal suspension with a mint aroma flavour.
The primary packaging material of the product Hezkue® consists of high-density polyethylene (HDPE) translucent bottles that contains 30 ml of drug product, closed with a high-density polyethylene (HDPE) child-resistant cap. The box contains a metering pump of 0.5 ml per pump as the administration device.
OR
This leaflet was last revised in December 2024
Aspargo Labs Italia S,r,L, Via Po, 102, Rome, 00198, Italy
AAH, Alliance, Pheonix